The role of the insulin-like growth factor system in prenatal growth

Ruvdeep Randhawa1, Pinchas Cohen

  • 1Division of Endocrinology, Department of Pediatrics, Mattel Children's Hospital at UCLA, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA.

Insights

Fetal growth restriction (FGR) involves genetic and environmental factors impacting infant development. The insulin-like growth factor (IGF) axis is crucial, and understanding its role in FGR is key for diagnosis and treatment.

Area of Science:

  • Reproductive Biology
  • Developmental Biology
  • Endocrinology

Background:

  • Fetal growth restriction (FGR) is linked to significant morbidity in neonates and later in life.
  • The insulin-like growth factor (IGF) axis is recognized for its critical role in fetal and postnatal development.
  • The precise mechanisms by which maternal factors contribute to FGR via the IGF axis are not fully understood.

Purpose of the Study:

  • To investigate the role of the insulin-like growth factor (IGF) axis in fetal growth restriction (FGR).
  • To explore how genetic and environmental factors, particularly maternal influences, impact fetal growth through the IGF pathway.
  • To identify potential diagnostic and therapeutic targets for FGR by elucidating IGF axis involvement.

Main Methods:

  • Review of genetic studies in humans and mice involving IGF ligands (IGF1, IGF2), IGF type-I receptor, and IRS1.
  • Analysis of IGF levels in newborns with small for gestational age (SGA).
  • Exploration of the interplay between maternal nutrient supply, placental function, and fetal growth regulation via the IGF axis.

Main Results:

  • Mutations in IGF ligands, IGF type-I receptor, or IRS1 are associated with FGR in humans and mice.
  • Low IGF levels are observed in human SGA newborns, though genetic mutations are rare.
  • Idiopathic FGR is often attributed to maternal factors, suggesting complex regulatory pathways.

Conclusions:

  • The IGF axis plays a fundamental role in regulating fetal growth.
  • Maternal factors significantly influence fetal development, potentially through subtle alterations in the IGF axis.
  • Further research into genetic variations, polymorphisms, and epigenetic regulation of the IGF axis may explain many idiopathic FGR cases.

Related Concept Videos

Insulin: The Receptor and Signaling Pathways01:28

Insulin: The Receptor and Signaling Pathways

Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but this inhibition is released...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Nature and Nurture01:10

Nature and Nurture

Many human characteristics, like height, are shaped by both nature—in other words, by our genes—and by nurture, or our environment. For example, chronic stress during childhood inhibits the production of growth hormones and consequently reduces bone growth and height. Scientists estimate that 70-90% of variation in height is due to genetic differences among individuals, and 10-30% of variation in height is due to differences in the environments that individuals experience, such as differences...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
Genomic Imprinting and Inheritance02:30

Genomic Imprinting and Inheritance

Diploid organisms inherit genetic material through chromosomes from both parents. Copies of the same gene are known as alleles. In most cases, both alleles are simultaneously expressed and allow various cellular processes to function optimally. If one of the alleles is missing or mutated, the expression of the other allele can compensate; however, this is not true for all genes.
The expression of some genes depends on which parent passed the gene to the offspring, through a phenomenon known as...